The initial reporter stated they received discrepant results for 52 patient samples tested with the elecsys il-6 assay on a cobas e 411 immunoassay analyzer.The results did not compare to results obtained with competitor methods.It was asked, but it is not known if any incorrect results were reported outside of the laboratory.The first sample initially resulted in an il-6 value of < 1.50 pg/ml accompanied by a data flag when tested on the e411.The sample was repeated twice using the vector-best elisa method and the siemens immulite analyzer.With each competitor method, the result was 300 pg/ml.The sample was diluted and repeated on the e411 analyzer on (b)(6) 2021, resulting in a value of < 1.50 pg/ml accompanied by a data flag.The second sample initially resulted in an il-6 value of 8.45 pg/ml when tested on the e411.The sample was repeated twice using the vector-best elisa method and the siemens immulite analyzer.With each competitor method, the result was 300 pg/ml.The sample was diluted and repeated on the e411 analyzer on (b)(6) 2021, resulting in a value of 5.84 pg/ml.The reporter later provided data for an additional 50 patient samples with discrepant il-6 results.Data from these samples (samples 3 -52).These samples are from patients with a confirmed diagnosis of covid-19.The serial number of the e411 analyzer is (b)(4).
|